Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective oestrogen receptor modulators--current and future brain and behaviour applications.

U Halbreich1, L S Kahn

  • 1School of Medicine and Biomedical Sciences, SUNY Clinical Center, Room BB170, 462 Grider Street, Buffalo, NY 14215, USA. urielh@acsu.buffalo.edu

Expert Opinion on Pharmacotherapy
|March 16, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of junior faculty in resource-poor departments of psychiatry.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
Same author

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment.

Pharmacopsychiatry·2009
Same author

Women's mental health in the Muslim world: cultural, religious, and social issues.

Journal of affective disorders·2007
Same author

Mental health of Moroccan women, a sexual perspective.

Journal of affective disorders·2006
Same author

What does Chilean research tell us about postpartum depression (PPD)?

Journal of affective disorders·2006
Same author

The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2005

Selective oestrogen receptor modulators (SERMs) offer targeted benefits for bone, cardiovascular, and reproductive systems. Emerging research suggests potential for central nervous system (CNS) applications, including cognitive enhancement and neuroprotection.

Area of Science:

  • Endocrinology and Pharmacology
  • Neuroscience
  • Oncology

Background:

  • Selective oestrogen receptor modulators (SERMs) exhibit tissue-specific agonist/antagonist activity.
  • SERMs are established treatments for breast cancer, osteoporosis, and cardiovascular disease.
  • Oestrogen significantly impacts the central nervous system (CNS), influencing cognition and mood.

Purpose of the Study:

  • To explore the potential of SERMs for targeted CNS applications.
  • To review the current understanding of SERM effects on the CNS.
  • To identify future directions for CNS-targeted SERM development.

Main Methods:

  • Literature review of SERM mechanisms and oestrogen's CNS effects.
  • Analysis of existing data on SERM activity in the CNS.

Related Experiment Videos

  • Discussion of potential clinical trial targets for CNS-active SERMs.

    • Main Results:

    • Oestrogen influences cognition, Alzheimer's dementia, well-being, and antidepressant response.
    • Current SERMs like tamoxifen and raloxifene may possess oestrogen agonist CNS effects in postmenopausal women.
    • SERM effects in women of reproductive age and men are less understood, potentially showing antagonist activity.

    Conclusions:

    • The CNS presents a promising area for novel SERM development.
    • Further research is needed to fully elucidate SERM CNS effects and optimize their therapeutic potential.
    • Clinical trials for CNS-targeted SERMs are anticipated due to growing knowledge and market demand.